Parameter | Estimate | 95% CI | se | df | t-value | p-value |
---|---|---|---|---|---|---|
Intercept | 67.757 | 62.225, 73.518 | 2.662 | 431 | 25.456 | ≤ 0.000 |
BD: subtype-2 | 3.191 | 0.146, 0.645 | 1.578 | 431 | 2.023 | 0.044 |
Clinical follow-up attendance | − 0.008 | 0.407, 6.908 | 0.029 | 431 | − 0.287 | 0.774 |
GAF baseline | 0.410 | 0.019, 0.308 | 0.114 | 431 | 3.586 | ≤ 0.000 |
Age of onset | 0.120 | − 4.657, 2.122 | 0.072 | 431 | 1.672 | 0.095 |
Anxiety disorder | − 2.162 | − 4.823, 0.498 | 1.354 | 431 | − 1.597 | 0.111 |
ADHD | 1.279 | − 2.979, 5.537 | 2.166 | 431 | 0.591 | 0.555 |
Substance use disorder | 1.552 | − 0.869, 3.973 | 1.232 | 431 | 1.260 | 0.208 |
Sex: male | 0.771 | − 1.650, 3.192 | 1.232 | 431 | 0.626 | 0.532 |
Income-2a | − 0.551 | − 3.261, 2.160 | 1.379 | 431 | − 0.399 | 0.690 |
Income-3a | 3.572 | 0.474, 6.670 | 1.576 | 431 | 2.266 | 0.024 |
BD subtype-2: GAF baseline | − 0.265 | − 0.518, − 0.012 | 0.129 | 431 | − 2.059 | 0.040 |
BD subtype-2: age of onset | − 0.244 | − 0.518, − 0.029 | 0.139 | 431 | − 1.758 | 0.080 |
Anxiety disorder: ADHD | − 6.953 | − 13.222,− 0.683 | 3.190 | 431 | − 2.180 | 0.030 |